NKT seeks to increase share issuance authorization at
Company Announcement 22 February 2023 Announcement No. 1 NKT seeks to increase share issuance authorization at Annual
Globe Newswire22-02-2023, 13:43
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) 27-01-2025, 18:00